Avanos Medical, Inc.AVNSNYSE
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+262.6%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+262.6%/yr
Quarterly compound
Percentile
P90
Near historical high
vs 3Y Ago
47.7x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 364.29% |
| Q3 2025 | 98.18% |
| Q2 2025 | -1263.64% |
| Q1 2025 | 101.66% |
| Q4 2024 | -9339.53% |
| Q3 2024 | 138.89% |
| Q2 2024 | 300.00% |
| Q1 2024 | -108.57% |
| Q4 2023 | 383.78% |
| Q3 2023 | 94.57% |
| Q2 2023 | -13520.00% |
| Q1 2023 | -102.96% |
| Q4 2022 | 7.64% |
| Q3 2022 | 25.60% |
| Q2 2022 | 131.48% |
| Q1 2022 | -46.00% |
| Q4 2021 | 128.49% |
| Q3 2021 | -192.61% |
| Q2 2021 | 598.68% |
| Q1 2021 | 83.90% |
| Q4 2020 | -344.56% |
| Q3 2020 | 743.33% |
| Q2 2020 | -181.08% |
| Q1 2020 | 160.66% |
| Q4 2019 | 46.96% |
| Q3 2019 | -43.75% |
| Q2 2019 | 60.59% |
| Q1 2019 | -822.73% |
| Q4 2018 | -152.38% |
| Q3 2018 | -88.10% |
| Q2 2018 | 412.39% |
| Q1 2018 | -134.45% |
| Q4 2017 | 97.59% |
| Q3 2017 | -2.92% |
| Q2 2017 | 33.59% |
| Q1 2017 | 28.00% |
| Q4 2016 | 9.89% |
| Q3 2016 | 40.00% |
| Q2 2016 | -54.23% |
| Q1 2016 | -2.07% |